| Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers T Dufourd, N Robil, D Mallet, C Carcenac, S Boulet, S Brishoual, E Rabois, ... Biology Methods and Protocols 4 (1), bpz006, 2019 | 49 | 2019 |
| A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models D Mallet, T Dufourd, M Decourt, C Carcenac, P Bossù, L Verlin, ... The Journal of clinical investigation 132 (4), 2022 | 16 | 2022 |
| Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use R Goutaudier, F Joly, D Mallet, M Bartolomucci, D Guicherd, C Carcenac, ... Molecular Psychiatry 28 (1), 463-474, 2023 | 10 | 2023 |
| Re-routing metabolism by the mitochondrial pyruvate carrier inhibitor MSDC-0160 attenuates neurodegeneration in a rat model of Parkinson’s disease D Mallet, R Goutaudier, EL Barbier, S Carnicella, JR Colca, F Fauvelle, ... Molecular Neurobiology 59 (10), 6170-6182, 2022 | 9 | 2022 |
| Early diagnosis of Parkinson’s disease: A cross-species biomarker D Mallet, T Dufourd, M Decourt, C Carcenac, P Bossù, L Verlin, ... bioRxiv, 2021.10. 04.462993, 2021 | 1 | 2021 |
| Metabolic markers specific to neurodegenerative diseases such as parkinson's disease and use thereof in diagnosis S Boulet, F Fauvelle, D Mallet US Patent App. 18/032,384, 2023 | | 2023 |
| Recherche de biomarqueur des phases précoces de la maladie de Parkinson pour le diagnostic et la compréhension des mécanismes physiopathologiques: Etude translationnelle de l … D Mallet Université Grenoble Alpes [2020-....], 2022 | | 2022 |
